Market Closed

IBIO
iBio
$ 0.7317
-4.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago

iBio News

Latest iBio Stock News & IBIO Headlines

iBio Reports Q1 Fiscal Year 2027 Financial Results and Provides Corporate Update
5 days ago | globenewswire.com
iBio to Participate in Upcoming Investor Conferences
13 days ago | globenewswire.com
iBio Highlights Data from a Non-human Primate Study Supporting IBIO-610's Potential to Preserve Muscle in Combination with GLP-1 Therapy
a month ago | globenewswire.com
Squarepoint Ops LLC Makes New Investment in iBio, Inc. $IBIO
2 months ago | defenseworld.net
iBio to Participate in the 2026 Wells Fargo Annual Healthcare Conference
2 months ago | globenewswire.com
iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update
3 months ago | globenewswire.com
iBio Strengthens Clinical Leadership with Appointment of Endocrinologist Molly Carr as Chief Medical Officer
3 months ago | globenewswire.com
iBio Reports Single Dose of IBIO-610 Achieved Near-Complete Active Activin E Inhibition Through Eight Weeks in Obese NHP Study
4 months ago | globenewswire.com
iBio to Participate in Upcoming Healthcare Investor Conferences
5 months ago | globenewswire.com
iBio Becomes a Clinical-Stage Company with First Participant Dosed in Phase 1 Clinical Trial of IBIO-600 in Adults with Obesity
5 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

IBIO
iBio
$ 0.7317
-4.00%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated 2 days ago